Search

Search results

90 results found

Population structure of ocular Streptococcus pneumoniae is highly diverse and formed by lineages that escape current vaccines

Publication: Journal Article

Andre, Camille, John Rouhana, Suelen Scarpa Mello, Gabriela Rosa Cunha, Andrew Van Camp, Michael Gilmore, and Paulo Bispo. 2022. “Population Structure of Ocular Streptococcus Pneumoniae Is Highly Diverse and Formed by Lineages That Escape Current Vaccines”. Microb Genom 8 (3).

Clinicians' Use of Quantitative Information while Assessing the Rate of Functional Progression in Glaucoma

Publication: Journal Article

Gardiner, Stuart, Robert Kinast, Carlos Gustavo De Moraes, Donald Budenz, Jin Wook Jeoung, John Lind, Jonathan Myers, et al. 2022. “Clinicians’ Use of Quantitative Information While Assessing the Rate of Functional Progression in Glaucoma”. Ophthalmol Glaucoma 5 (5): 498-506.

eye Insights 14: Genetic Therapies for Inherited Retinal Disorders

Page

While gene therapy is not yet widely available for inherited retinal disorsers (IRDs), researchers are making exciting discoveries, and the future looks more promising than ever before. In this issue of eye Insights, we provide a look into current offerings in gene therapy, and a glimpse into the...

IRDs and Genetic Testing

Page

Inherited retinal disorders are rare, hereditary disorders caused by mutations in genes that encode proteins needed for normal retinal health and function. The first gene associated with retinitis pigmentosa was identified at Mass Eye and Ear in 1990, and since then, over 250 IRD-causing genes have...

Current Gene Therapies for IRDs

Page

The first gene-augmentation therapy for an IRD was approved by the U.S. Food and Drug Administration (FDA) in December 2017 after nearly two decades of development in preclinical models and clinical trials. The drug, known as Luxturna®, is for individuals with autosomal recessive retinal dystrophies...

Deborah VanderVeen, MD, Inducted into the American Ophthalmological Society

News: March 03, 2022

Deborah K. VanderVeen, MD, Associate Professor of Ophthalmology at Harvard Medical School and a clinician scientist at Boston Children's Hospital, has been elected to the prestigious American Ophthalmological Society for her distinguished contributions to the field, particularly her work in...

Paulo Bispo, PhD, Awarded ARVO Foundation Fellowship

News: January 07, 2022

Paulo Bispo, PhD, Assistant Professor of Ophthalmology at Harvard Medical School and Assistant Scientist at Mass Eye and Ear, received the 2022 Association for Research in Vision and Ophthalmology (ARVO) Mallinckrodt Uveitis Research Fellowship. This $45,000 fellowship award will fund Dr. Bispo's...

Leo Kim, MD, PhD, and John Miller, MD, to Participate in Course that Fosters Collaboration Between Academia and Industry

News: January 07, 2022

Leo Kim, MD, PhD, Associate Professor of Ophthalmology at Harvard Medical School (HMS) and the Monte J. Wallace Ophthalmology Chair in Retina at Mass Eye and Ear, and John Miller, MD, Assistant Professor of Ophthalmology at HMS and Director of Retinal Imaging at Mass Eye and Ear, were selected to...

Inês Laíns, MD, PhD, Receives VitreoRetinal Surgery Foundation Research Award

News: January 07, 2022

Inês Laíns, MD, PhD, a PGY-4 resident, is a 2021 recipient of a VitreoRetinal Surgery Foundation Research Award. This award will support her research project "Swept-source OCT and OCTA predictors of postoperative visual outcomes after macula-off retinal detachment."

HMPA Movie Night

News: March 11, 2022

What is the best way to unwind on a Friday evening? Of course, Netflix!! Come watch a movie with HMPA on Friday at 6pm. We promise it will be fun! Eventbrite link: https://www.eventbrite.com/e/movie-night-tickets-294672412117